中国生物制造总规模达到1.1万亿元

Core Insights - The total scale of China's biomanufacturing industry has reached 1.1 trillion yuan, with bioproducts accounting for over 70% of global production [1] - The annual output value of both food and pharmaceutical biomanufacturing segments exceeds 400 billion yuan [1] - China has established a number of national key laboratories and industrial innovation platforms, with over 20% of global research papers and patent applications originating from the country [1] Group 1 - The biomanufacturing sector is recognized as a crucial form of material production for the future and is expected to be a core driver of the Fourth Industrial Revolution [1] - Traditional bioproducts such as vitamins, amino acids, and antibiotics continue to reduce costs and enhance efficiency, maintaining a global competitive edge [1] - Emerging products like hyaluronic acid and glucosamine are improving in quality, steadily increasing their global market share [1] Group 2 - The conference emphasized the need to strengthen technological research and innovation to address fundamental scientific issues and major engineering bottlenecks in the biomanufacturing industry [2] - It highlighted the importance of collaboration among industry, academia, and research institutions to create a synergistic development model [2] - The conference released several lists, including the first batch of high-performance bioreactor innovation task units and notable biomanufacturing products [2]